Advanced or Metastatic Solid Tumours

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Akesobio
AkesobioChina - Zhongshan
1 program
1
AK127Phase 11 trial
Active Trials
NCT05021120CompletedEst. Apr 2025
Aptose Biosciences
Aptose BiosciencesCA - San Diego
1 program
1
LOR-253 HClPhase 11 trial
Active Trials
NCT01281592CompletedEst. Jan 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AkesobioAK127
Aptose BiosciencesLOR-253 HCl

Clinical Trials (2)

NCT05021120AkesobioAK127

A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours

Start: Oct 2021Est. completion: Apr 2025
Phase 1Completed
NCT01281592Aptose BiosciencesLOR-253 HCl

A Study of LOR-253 HCl in Patients With Advanced or Metastatic Solid Tumours

Start: Jan 2011Est. completion: Jan 2014
Phase 1Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
2h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
2h ago

Office Administrator

SystImmune
2h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
3h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
3h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
3h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)